TickerFacts.

Incyte Corp (INCY): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$4.77B
Year ended 2025-12-31
$4.96B
Trailing 12 months to 2026-03-31
+14.4%
3-year compound annual growth
2016-12-31: $1.05B2017-12-31: $1.46B2018-12-31: $1.79B2019-12-31: $2.04B2021-12-31: $2.84B2022-12-31: $3.19B2023-12-31: $3.44B2024-12-31: $3.93B2025-12-31: $4.77B$4.77B
2016-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$4.77B+21.4%2026-02-10, From 2025-01-01
2024-12-31$3.93B+14.2%2026-02-10, From 2024-01-01
2023-12-31$3.44B+7.9%2026-02-10, From 2023-01-01
2022-12-31$3.19B+12.4%2025-02-10, From 2022-01-01
2021-12-31$2.84Bn/a2024-02-13, From 2021-01-01
No annual figure between 2019-12-31 and 2021-12-31.
2019-12-31$2.04B+14.4%2022-02-08, From 2019-01-01
2018-12-31$1.79B+22.7%2021-02-09, From 2018-01-01
2017-12-31$1.46B+39.1%2020-02-13, From 2017-01-01
2016-12-31$1.05Bn/a2019-02-14, From 2016-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Incyte Corp (INCY)2025-12-31$4.77B+21.4%
Icon PLC (ICLR)2024-12-31$2.34B+0.4%
MaxCyte, Inc. (MXCT)2025-12-31$26.80M-15.0%
iSpecimen Inc. (ISPC)2025-12-31$24.1K-99.4%
OneMedNet Corp (ONMD)2025-12-31-$503.0Kn/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31$262.9K+29.4%
Weed, Inc. (BUDZ)2025-12-31$0n/a
Vitaspring Biomedical Co. Ltd. (VSBC)2026-01-31$0n/a

Compare INCY, ICLR, MXCT, ISPC side by side · Screen every company in Services-Commercial Physical & Biological Research ↗